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All reactions were carried out under a positive pressure of argon at room temperature unless 
otherwise noted. For column chromatography, Silica Gel 60 N (spherical, neutral, Kanto Chemical 
Co.,Inc.) was employed. Preparative TLC was performed on precoated plates (1 mm silica gel, 
Merck KGaA 60F254). Mass spectra were recorded on a Waters MICROMASS® LCT PREMIERTM 
(ESI-TOF). NMR spectra were recorded using a Bruker AV400N at 400 MHz frequency for 1H, and 
JEOL JNM-AL300 at 300 MHz frequency for 1H and 75 MHz frequency for 13C (signals of 13C 
connected to boron were not detected). For HPLC separations, a Cosmosil 5C18-AR-II analytical 
column (Nacalai Tesque, 4.6 × 250 mm, flow rate 1.0 mL/min), a Cosmosil 5C18-AR-II 
semi-preparative column (Nacalai Tesque, 10 × 250 mm, flow rate 3.0 mL/min) or a Cosmosil 
5C18-AR-II preparative column (Nacalai Tesque, 20 × 250 mm, flow rate 10.0 mL/min) was 
employed, and eluting products were detected by UV at 220 nm. A solvent system consisting of 
0.1% (v/v) TFA in H2O (solvent A) and 0.1% TFA (v/v) in MeCN (solvent B) was used for HPLC 
elution. Optical rotations were measured using a JASCO P-2200 polarimeter (concentration in g/100 
mL). 
 
Synthesis of hydrogen peroxide-responsive amino acid derivatives 2 and 3 
 
Scheme S1. Reagents and conditions: a) 6, K2CO3, KI, DMF, 92%; b) AcOH, THF, H2O, 98%; c) PDC, DMF; d) NaClO2, NaH2PO4, 
2-methyl-2-butene, t-BuOH, acetone, H2O, 71% (two steps); e) NaHCO3, MeOH, H2O; f) 4 M HCl in EtOAc; g) FmocOSu, Na2CO3, MeCN, H2O, 
77% (three steps) for 2, 44% (two steps) for 3; h) TBSOTf, 2,6-lutidine, CH2Cl2; i) SOCl2, DMF, CH2Cl2, 67%. 
 
2-{4-(Chloromethyl)phenyl}-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione (6) 
To a stirred solution of benzyl alcohol 5 [S1] (1.00 g, 3.80 mmol) in DMF (8.0 µL) and CH2Cl2 (7.6 
mL) was added thionyl chloride (331 µL, 4.45 mmol) at 0 °C. The reaction mixture was stirred for 
17 h, and then EtOAc, MeCN, H2O and saturated aqueous solution of NaHCO3 were added to the 
mixture. After extraction with EtOAc, the combined organic layer was washed with brine, dried over 
Na2SO4, and concentrated in vacuo. The product was purified by column chromatography 
(Et2O/MeCN = 2/1 (v/v)) and 719 mg of chloride 6 (2.55 mmol, 67%) was obtained as a white solid: 
1H NMR (CD3CN, 400 MHz) δ = 2.50 (3H, s), 3.90 (2H, d, J = 17.0 Hz), 4.07 (2H, d, J = 17.0 Hz), 
 S3
4.68 (2H, s), 7.43 (2H, d, J = 8.0 Hz), 7.52 (2H, d, J = 8.0 Hz); 13C NMR (CD3CN, 75 MHz) δ = 
47.0, 48.4, 62.7, 129.1, 133.8, 139.8, 169.4; HRMS (ESI-TOF) m/z calcd for C12H14BClNO4 ([M + 




To a stirred solution of phenol 4[S2] (400 mg, 0.914 mmol) in DMF (8.0 mL) were added K2CO3 (303 
mg, 2.19 mmol), benzyl chloride derivative 6 (514 mg, 1.83 mmol), and potassium iodide (364 mg, 
2.19 mmol), and the resulting suspension was stirred for 2 d. After addition of EtOAc and saturated 
aqueous solution of NH4Cl, the reaction mixture was stirred for additional 30 min. The mixture was 
then extracted with EtOAc, and the combined organic layer was washed with water, saturated 
aqueous solution of NH4Cl and brine. The extract was dried over Na2SO4 and concentrated in vacuo. 
The product was purified by column chromatography (hexane/EtOAc = 2/1 then 1/6 (v/v)) and 574 
mg of MIDA boronate 7 (0.841 mmol, 92%) was obtained as a pale yellow amorphousness: [α]20D 
-29.9 (c 1.22, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = -0.06 (3H, s), -0.05 (3H, s), 0.84 (9H, s), 
1.39 (9H, s), 1.49 (3H, s), 1.53 (3H, s), 2.20 (3H, s), 2.53 (3H, s), 2.55 (3H, s), 3.48 (1H, dd, J = 10.4 
and 4.0 Hz), 3.55 (1H, dd, J = 10.4 and 4.0 Hz), 3.80 (2H, d, J = 16.8 Hz), 4.07 (2H, d, J = 16.8 Hz), 
4.60 (1H,br m), 4.84 (1H, d, J = 10.0 Hz), 5.06 (1H, d, J = 12.4 Hz), 5.13 (1H, d, J = 12.4 Hz), 6.56 
(1H, s), 6.59 (1H, s), 7.49-7.52 (4H, m); 13C NMR (CDCl3, 75 MHz) δ = -5.6, -5.5, 18.1, 20.7, 25.8, 
25.9, 27.5, 28.4, 29.2, 44.8, 47.6, 56.3, 61.7, 63.8, 70.8, 78.3, 112.7, 127.3, 127.7, 131.0, 132.4, 
136.2, 138.5, 139.3, 156.0, 158.6, 167.9; HRMS (ESI-TOF) m/z calcd for C36H55BN2NaO8S ([M + 




Glacial acetic acid (3.41 mL) and water (3.41 mL) were added to a solution of silyl ether 7 (430 mg, 
0.630 mmol) in THF (10 mL). The reaction mixture was stirred for 14 h and was diluted with water. 
After extraction with EtOAc, the organic phase was washed with water (×2) followed by brine, dried 
over Na2SO4, and concentrated in vacuo. The crude product was purified by column chromatography 
(hexane/EtOAc = 1/10 then Et2O/MeCN = 4/1 (v/v)) and 352 mg of alcohol 8 (98.9 µmol, 98%) was 
obtained as a white amorphousness: [α]20D -18.5 (c 1.04, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 
1.36 (9H, s), 1.47 (3H, s), 1.49 (3H, s), 2.21 (3H, s), 2.50 (3H, s), 2.55 (3H, s), 3.45 (1H, dd, J = 10.4 
and 8.4 Hz), 3.58 (1H, d, J = 9.6 Hz), 3.81 (2H, d, J = 16.6 Hz), 4.04 (2H, d, J = 16.6 Hz), 4.49-4.53 
(1H, m), 4.91 (1H, d, J = 8.4 Hz), 5.06 (1H, d, J = 12.0 Hz), 5.10 (1H, d, J = 8.4 Hz), 6.57 (1H, s), 
6.64 (1H, s), 7.49 (2H, d, J = 7.8 Hz), 7.54 (2H, d, J = 7.8 Hz); 13C NMR (CDCl3, 75 MHz) δ = 20.7, 
25.9, 27.9, 28.3, 28.6, 43.8, 47.6, 59.0, 61.8, 64.3, 71.0, 79.2, 112.8, 127.6, 127.9, 130.3, 132.6, 
 S4
136.6, 138.2, 138.8, 157.2, 158.5, 167.9; HRMS (ESI-TOF) m/z calcd for C30H42BN2O8 ([M + H]+) 
569.3034, found 569.3051. 
 
(S)-2-{(tert-Butoxycarbonyl)amino}-3-(2,4-dimethyl-6-[{4-(6-methyl-4,8-dioxo-1,3,6,2-dioxaza- 
borocan-2-yl)benzyl}oxy]phenyl)-3-methylbutanoic acid (9) 
Pyridinium dichromate (937 mg, 2.49 mmol) was added to a solution of alcohol 8 (283 mg, 0.497 
mmol) in DMF (2.4 mL). The reaction mixture was stirred for 13 h. After addition of Celite 535, the 
obtained mixture was filtered through Celite 535. The filtrate was washed with 5% (v/v) aqueous 
solution of KHSO4 followed by brine, dried over Na2SO4, and concentrated in vacuo. The resulting 
crude aldehyde was subjected to subsequent reaction without further purification. To a solution of 
the crude aldehyde in acetone (9.34 mL)/t-BuOH (6.41 mL)/H2O (1.54 mL) were added 
2-methyl-2-butene (0.355 mL, 3.35 mmol), NaH2PO4 (89.5 mg, 0.746 mmol) and NaClO2 (236 mg, 
2.61 mmol), and the mixture was stirred for 3 h. After addition of saturated aqueous solution of 
NH4Cl, the reaction mixture was extracted with EtOAc. The organic phase was dried over Na2SO4 
and was concentrated in vacuo. The obtained crude product was purified by column chromatography 
(Et2O/MeCN = 5/1 then 1/1 (v/v)) and 207 mg of Boc amino acid 9 (0.354 mmol, 71% (two steps)) 
was obtained as a pale yellow amorphousness: [α]20D 7.53 (c 1.16, CHCl3); 1H NMR (DMSO-d6, 400 
MHz, 60 °C) δ = 1.25 (9H, s), 1.44 (3H, s), 1.52 (3H, s), 2.13 (3H, s), 2.42 (3H, s), 2.49 (3H, s), 4.06 
(2H, d, J = 17.1 Hz), 4.28 (2H, d, J = 17.1 Hz), 5.06 (1H, d, J = 12.6 Hz), 5.13 (1H, d, J = 12.6 Hz), 
5.21 (1H, d, J = 9.6 Hz), 6.18 (1H, br s), 6.46 (1H, s), 6.70 (1H, s), 7.43 (2H, d, J = 8.0 Hz), 7.51 
(2H, d, J = 8.0 Hz); 13C NMR (DMSO-d6, 75 MHz, 60 °C) δ = 20.4, 25.3, 27.8, 27.9, 28.1, 43.3, 
47.6, 58.9, 61.7, 70.2, 77.7, 112.7, 126.4, 127.1, 129.7, 132.4, 135.4, 137.3, 138.2, 155.4, 158.2, 




phenyl]-3-methylbutanoic acid (2) 
To an MIDA boronate 9 (210 mg, 0.361 mmol) in MeOH (5.6 mL) was added saturated aqueous 
solution of NaHCO3 (2.78 mL), and the suspension was stirred for 3 h. After addition of saturated 
aqueous solution of NH4Cl, the reaction mixture was extracted with EtOAc. The combined organic 
layer was washed with brine, dried over Na2SO4, and concentrated in vacuo. The crude material was 
dissolved in hydrogen chloride in EtOAc (4 M, 2.78 mL) and the mixture was stirred for 1 h. After 
concentration in vacuo, MeCN (5.92 mL) and 10% (v/v) aqueous solution of Na2CO3 (1.93 mL) 
were added to the resulting residue. After addition of FmocOSu (134 mg, 0.397 mmol), the mixture 
was stirred for 14 h. Then the reaction mixture was acidified with 5% (v/v) aqueous solution of 
KHSO4. The resulting mixture was extracted with EtOAc. The organic layer was washed with brine, 
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and concentrated in vacuo. The crude product was purified by preparative TLC (CHCl3/MeOH = 
10/1 (v/v)) and 165 mg of boronic acid 2 (0.728 mmol, 77% (three steps)) was obtained as a pale 
yellow amorphousness. For large scale purification, column chromatography (CHCl3/MeOH = 99/1 
then 20/1 (v/v)) was employed: [α]20D -10.4 (c 1.03, CHCl3); 1H NMR (DMSO-d6, 300 MHz, 80 °C) 
δ = 1.79 (3H, s), 1.86 (3H, s), 2.36 (3H, s), 2.75 (3H, s), 4.30-4.36 (2H, m), 4.47 (1H, dd, J = 13.0 
and 10.4 Hz), 5.33 (1H, d, J = 12.5 Hz), 5.39 (1H, d, J = 12.5 Hz), 5.66 (1H, d, J = 9.7 Hz), 6.73 (1H, 
s), 6.96 (1H, s), 7.09 (1H, br s), 7.53 (2H, t, J = 7.5 Hz), 7.64 (2H, t, J = 7.2 Hz), 7.74 (2H, d, J = 7.9 
Hz), 7.84 (1H, d, J = 9.3 Hz), 7.87 (1H, d, J = 9.3 Hz), 7.93 (2H, s), 8.03 (2H, d, J = 7.9 Hz), 8.09 
(2H, d, J = 7.5 Hz), 12.3 (1H, br s); 13C NMR (DMSO-d6, 75 MHz, 80 °C) δ = 20.3, 25.3, 27.8, 27.9, 
43.6, 46.6, 59.4, 65.7, 70.2, 112.5, 119.9, 120.0, 125.3, 125.6, 126.2, 126.9, 127.0, 127.2, 127.5, 
127.6, 129.5, 134.1, 135.4, 137.3, 139.3, 140.5, 140.6, 143.7, 143.9, 156.1, 158.1, 173.3; HRMS 
(ESI-TOF) m/z calcd for C35H37BNO7 ([M + H]+) 594.2663, found 594.2684. 
 
(S)-2-([{(9H-Fluoren-9-yl)methoxy}carbonyl]amino)-3-(2,4-dimethyl-6-[{4-(6-methyl-4,8-di- 
oxo-1,3,6,2-dioxazaborocan-2-yl)benzyl}oxy]phenyl)-3-methylbutanoic acid (3) 
To a solution of Boc derivative 9 (100 mg, 0.172 mmol) in CH2Cl2 (3.8 mL) were added 2,6-lutidine 
(0.120 mL, 1.03 mmol) and TBSOTf (0.158 mL, 0.668 mmol).[S3] The reaction mixture was stirred 
for 3 h. After concentration in vacuo, Fmoc protection of the obtained crude material was carried out 
as similar to that described for preparation of boronic acid 2. The product was purified by 
preparative TLC (Et2O/MeCN = 3/1 (v/v)) and 53.1 mg of MIDA ester 3 (57.4 µmol, 44% (two 
steps)) was obtained as a pale yellow amorphousness: [α]20D -15.6 (c 1.00, CHCl3); 1H NMR 
(DMSO-d6, 300 MHz, 100 °C) δ = 1.52 (3H, s), 1.59 (3H, s), 2.09 (3H, s), 2.47 (3H, s), 2.49 (3H, s), 
4.02-4.18 (3H, m), 4.04 (2H, d, J = 16.7 Hz), 4.28 (2H, d, J = 16.7 Hz), 5.07 (1H, d, J = 12.6 Hz), 
5.13 (1H, d, J = 12.6 Hz), 5.45 (1H, d, J = 9.6 Hz), 6.46 (1H, s), 6.70 (1H, s), 7.08 (1H, br s), 7.27 
(2H, t, J = 7.2 Hz), 7.36-7.63 (8H, m), 7.84 (2H, d, J = 7.5 Hz); 13C NMR (DMSO-d6, 75 MHz, 
100 °C) δ = 20.3, 25.3, 27.8, 27.9, 43.6, 46.6, 47.5, 59.2, 61.7, 65.7, 70.2, 112.6, 119.9, 120.0, 125.3, 
125.6, 126.5, 126.9, 127.0, 127.2, 127.5, 127.6, 129.5, 132.3, 135.4, 137.3, 138.1, 140.5, 140.6, 
143.6, 143.9, 156.0, 158.1, 169.3, 173.3; HRMS (ESI-TOF) m/z calcd for C40H42BN2O9 ([M + H]+) 









Preparation of hydrogen peroxide-responsive model peptide 12 
 
Scheme S2. Reagents and conditions: a) Fmoc SPPS; b) Fmoc SPPS. For removal of an Fmoc group, sat. Na2B4O7 
in 20% (v/v) piperidine/DMF was used; c) Fmoc SPPS. Before global deprotection, the resin was treated with sat. 
NaHCO3 aq./H2O/MeOH = 1/1/2 (v/v). Global deprotection conditions: TFA/triethylsilane/H2O = 95/2.5.2.5 (v/v). 
 
Preparation of peptide resin 10 or 11 
On NovaSyn® TGR resin (0.22 mmol amine/g) were coupled Fmoc protected naturally occurring 
amino acid derivatives (3 eq., a protective group of a side chain: t-Bu for serine and tyrosine) in the 
presence of N,N’-diisopropylcarbodiimide (DIC, 3.2 eq.) and 1-hydroxybenzotriazole hydrate 
(HOBt·H2O, 3 eq.) in DMF for 2 h. Coupling of H2O2-responsive unit 2 or 3 (2 eq.) was performed 
by the use of O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (1.95 
eq.) and N,N-diisopropylethyamine overnight. For Fmoc removal of the peptide resin, 20% (v/v) 
piperadine in DMF (10 min) was employed. 
  
Preparation of model peptide 12 from boronic acid derivative 10 
Fmoc protected amino acid derivatives (3 eq., a protective group of a side chain: t-Bu for aspartic 
acid and tyrosine; Pbf (2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl) for arginine; Trt for 
Gln) were coupled on peptide resin 10 in the presence of DIC (3.2 eq.) and HOBt·H2O (3 eq.) in 
DMF for 2 h. Removal of an Fmoc group was achieved by using saturated solution of Na2B4O7 in 
20% (v/v) piperadine/DMF for 10 min. The resulting completed resin was treated with 
TFA/triethylsilane/water (95/2.5/2.5 (v/v)) for 2 h. After filtration of the resin, cooled Et2O was 
added to the filtrate, and the resulting precipitate was collected by centrifugation. The obtained 
precipitate was washed with Et2O and was purified by preparative HPLC to give model peptide 12 
as a white lyophilized powder. Analytical HPLC conditions: linear gradient of solvent B in solvent A, 
1 to 50% over 30 min. Retention time = 21.7 min. Preparative HPLC conditions: linear gradient of 
solvent B in solvent A, 22 to 25% over 30 min. LRMS (ESI-TOF) m/z calcd for [M + 2H]2+ 762.9, 
found 762.7. 
 
Preparation of model peptide 12 from MIDA ester derivative 11 
On resin 11, a peptide chain was elongated as similar to that on 10. Removal of an Fmoc group was 
achieved without Na2B4O7. Before global deprotection, the resin was treated with a mixture of 
saturated aqueous solution of NaHCO3/H2O/MeOH (1/1/2 (v/v)) overnight to remove MIDA unit. 
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Then global deprotection of the peptide resin was conducted as mentioned above. 
 
Hydrogen peroxide-responsive peptide bond cleavage reaction 
To a solution of 2.0 mM peptide 12 in 6 M guanidine (5.5 µL) were added 20 mM sodium phosphate 
buffer with 100 mM glycine and 6 M guanidine hydrochloride (pH 7.4, 1072.5 µL), and 0.025% 
(w/v) benzamide in 20 mM phosphate buffer with 100 mM glycine and 6 M guanidine hydrochloride 
(11 µL) (Final concentration: 10 μM peptide 12, 6 M guanidine hydrochloride, 100 mM glycine, 25 
ppm benzamide, 20 mM phosphate). For HPLC analysis (reaction time = 0 h), 99 µL of the reaction 
mixture was used. Aqueous solution of H2O2 (0, 1, or 10 mM, 10 µL) was then added to the 
remaining reaction mixture (990 µL), and the reaction was performed at 37 °C (final concentration 
of H2O2: 0, 10, or 100 µM respectively). Progress of the reaction was monitored by HPLC and the 
peptides were characterized by ESI-TOF MS. Percentage of remaining 12 was estimated based on 
HPLC peak area. Relative amount of 13 and 15 + 16 was calculated using the following equation in 
which PAx means peak area of x in HPLC chromatogram. 
 
Relative amount of 13 or 15 + 16 = {PA13 or (PA15 + PA16)} × PAIS (t = 0) ÷ (PAIS × PA12 (t = 0)) 
 
12: Retention time = 21.7 min.  
13: Retention time = 22.1 min. LRMS (ESI-TOF) m/z calcd for [M + 2H]+ 748.9, found 748.7.  
15: Retention time = 22.6 min. LRMS (ESI-TOF) m/z calcd for [M + 2H]+ 405.7, found 405.8.  
16: Retention time = 11.0 min. LRMS (ESI-TOF) m/z calcd for [M + H]+ 581.3, found 581.3. 
Benzamide (internal standard): Retention time = 15.5 min.  
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